Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may increase the risk of new-onset type 2 diabetes (T2D) with a few observations substantiating concern. SARS-CoV-2 can infect pancreatic islet cells… Click to show full abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may increase the risk of new-onset type 2 diabetes (T2D) with a few observations substantiating concern. SARS-CoV-2 can infect pancreatic islet cells and metabolic complications can occur in people with coronavirus disease 2019 (COVID-19) who have no prior history of diabetes. Currently, there is limited epidemiological evidence to suggest a temporal association between SARS-CoV-2 infection and new-onset T2D.
               
Click one of the above tabs to view related content.